Doctor Kiran Bapatla
Novartis, Hyderabad (India)
Efficacy and safety of valsartan in children aged 1-5 years with hypertension, with or without chronic kidney disease: A 6-week randomised, multicentre, double-blind study followed by open-label phase
Event: ESC Congress 2019
Topic: Clinical
Session: Hypertension treatment: drugs and devices
ESC 365 is supported by
